Enteral Nutrition in Severe Acute Pancreatitis

Why Nutrition Matters

Severe acute pancreatitis (SAP) is characterised by intense inflammation, systemic response, and often, multiorgan failure. The early phase is marked by catabolism, fluid shifts and a high risk of infection. Adequate nutrition supports gut barrier integrity, modulates the immune response and reduces the incidence of infectious complications. Historically, patients were kept nilbymouth and fed parenterally, but mounting evidence now favours early enteral nutrition (EEN) as the preferred route.

Physiological Rationale for Enteral Feeding

Maintaining Gut Mucosal Integrity

Enteral delivery supplies luminal nutrients that stimulate mucosal blood flow, preserve tightjunction proteins and promote the production of secretory IgA. This limits bacterial translocation from the gut lumen to the bloodstream, a key driver of sepsis in SAP.

Modulating Inflammatory Pathways

Shortchain fatty acids produced by bacterial fermentation of fibrerich formulas have antiinflammatory effects. Moreover, early feeding attenuates the release of cytokines such as TNF, IL6 and IL1, dampening the systemic inflammatory response.

Preserving Immune Function

Enteral nutrition provides glutamine, arginine and omega3 fatty acids, substrates that support lymphocyte proliferation, macrophage activity and oxidative balance.

When to Start Enteral Nutrition

Guidelines from the American College of Gastroenterology, the American Society for Parenteral and Enteral Nutrition (ASPEN) and the International Association of Pancreatology all recommend initiating EEN within 2448hours of admission, provided there are no absolute contraindications such as intestinal perforation, uncontrolled hemorrhage, or severe ileus.

Early initiation (<24h) has been linked with lower rates of infectious complications and shorter intensivecare stays, without increasing the risk of exacerbating pancreatic inflammation.

Choice of Feeding Route

Nasogastric (NG) Tube

NG feeding is technically simple, can be placed at the bedside and is well tolerated in most patients. Multiple randomized trials have shown no significant difference in outcomes compared with nasojejunal (NJ) feeding, provided that gastric residual volumes are monitored.

Nasojejunal (NJ) Tube

Historically preferred to bypass the stomach and reduce pancreatic stimulation, NJ feeding remains useful when severe gastric distension, high residual volumes, or persistent vomiting occur. Endoscopic or fluoroscopic placement is required, which may delay nutrition.

Percutaneous Endoscopic Gastrostomy (PEG) or Jejunostomy (PEJ)

Considered only when prolonged feeding (>4weeks) is anticipated or when NG/NJ tubes fail. These are rarely needed during the acute phase of SAP.

Formula Selection

There is no universally superior formula; the choice should be patientcentred.

• Standard polymeric formulas adequate for most patients; contain balanced macronutrients and are costeffective.
• Peptidebased (semielemental) formulas may be useful in cases of severe malabsorption or when tolerance to polymeric formulas is poor.
• Immunemodulating formulas enriched with omega3 fatty acids, arginine and nucleotides; data suggest modest benefits in reducing infection rates.

Highfat, lowcarbohydrate regimens are not recommended because excessive fat delivery can stimulate pancreatic secretion through cholecystokinin release.

Practical Feeding Protocol

1. Verify tube placement with pH testing or radiography.
2. Start at 2030mL/h of polymeric formula.
3. Increase by 1020mL/h every 46hours if gastric residuals are <200mL and no abdominal distension or vomiting occurs.
4. Target full caloric intake (2530kcal/kg/day) within 4872hours.
5. Monitor electrolytes, glucose, triglycerides and liver enzymes daily.
6. Reassess tube position and tolerance at least every 12hours during the first 48hours.

Complications and Management

While generally safe, enteral feeding can be associated with:

• Tube displacement or blockage verify placement and flush with water before each feeding.
• Aspiration raise head of bed to 3045, consider postpyloric feeding if aspiration risk persists.
• Diarrhoea adjust infusion rate, consider fibercontaining or lowosmolar formulas.
• Hyperglycaemia treat with insulin protocol; many patients develop stressinduced hyperglycaemia.

Evidence Overview

Metaanalyses of randomized controlled trials consistently demonstrate that early enteral nutrition reduces infectious complications (odds ratio0.55) and mortality (relative risk0.78) compared with delayed feeding or parenteral nutrition. The benefits are most pronounced when feeding is started within 24hours and when gastric tolerance is monitored closely.

Key Recommendations (20232024 Guidelines)

• Start enteral nutrition within 2448hours of admission in all patients with SAP without contraindication.
• Prefer nasogastric route; switch to nasojejunal only if gastric intolerance occurs.
• Use standard polymeric formulas unless specific indications exist for peptidebased or immunemodulating feeds.
• Target 2530kcal/kg/day and 1.21.5g protein/kg/day.
• Monitor for aspiration, hyperglycaemia and electrolyte disturbances daily.